Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in mice BALB/c

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F12%3A43874634" target="_blank" >RIV/60162694:G44__/12:43874634 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Acetylcholine%20and%20an%20acetylcholinesterase%20inhibitor%20neostigmine%20can%20aggravate%20tularemia%20progress%20in%20mice%20BALB%2Fc" target="_blank" >http://www.ncbi.nlm.nih.gov/pubmed?term=Acetylcholine%20and%20an%20acetylcholinesterase%20inhibitor%20neostigmine%20can%20aggravate%20tularemia%20progress%20in%20mice%20BALB%2Fc</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2478/v10102-012-0004-7" target="_blank" >10.2478/v10102-012-0004-7</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in mice BALB/c

Popis výsledku v původním jazyce

The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected miceexposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.

Název v anglickém jazyce

Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in mice BALB/c

Popis výsledku anglicky

The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected miceexposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

CE - Biochemie

OECD FORD obor

—

Projekt

<a href="/cs/project/LH11023" target="_blank" >LH11023: Vylepšení vakcinační účinnosti pomocí cholinergní protizánětlivé dráhy</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Interdisciplinary Toxicology

ISSN

1337-6853

e-ISSN

—

Svazek periodika

5

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

SK - Slovenská republika

Počet stran výsledku

4

Strana od-do

21-24

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—